Rating Change
Barrington Research reiterated its Outperform rating on Haemonetics Corporation (NYSE:HAE) on August 19, 2026.
reiterateNYSE:HAE
Barrington Research Reiterates Outperform Rating on Haemonetics Corporation (HAE)
Barrington Research reiterated its Outperform rating on Haemonetics Corporation (NYSE:HAE) on August 19, 2026.
At publication ·
What changed
Haemonetics Corporation (NYSE:HAE) · reiterate
- Firm
- Barrington Research
- Rating
- Outperform to Outperform
- Price at event
- $108.41
- Market capitalization
- $4.1B
At a glance
Key takeaways
- Barrington Research reiterated an Outperform rating on Haemonetics Corporation (HAE) on August 19, 2026, with the stock trading at $108.41 and a market capitalization of $4.1 billion.
Market Context
Haemonetics Corporation operates in the Healthcare sector. The stock currently trades at $108.41 with a market capitalization of $4.1B. The stock has gained 94.7% over the past 52 weeks.
Analyst coverage from Barrington Research provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Haemonetics Corporation.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Haemonetics Corporation
Among the 10 most recent ratings: 7 Buy, 3 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Aug 19, 2026 | Barrington Research | Outperform | N/A |
| Aug 18, 2026 | BTIG | Buy | N/A |
| Aug 07, 2026 | JP Morgan | Neutral | N/A |
| Aug 07, 2026 | Citigroup | Neutral | N/A |
| Aug 06, 2026 | BTIG | Buy | N/A |
Related Tools: Analyst Ratings Dashboard | View HAE Stock Page
Frequently Asked Questions
What does the Outperform rating mean for HAE?
A rating of Outperform from Barrington Research reflects the analyst's outlook on Haemonetics Corporation (NYSE:HAE). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the HAE forecast page.